• Inductive Bio on a Winning Streak With ADMET Predictions

    Bio-IT World | Following on the heels of a similar victory in 2025, Inductive Bio earlier this year took home gold in an all-comers prediction competition focused on the properties of chemical compounds critical to drug development. In the latest OpenADMET-ExpansionRx blind challenge, Inductive Bio placed first among more than 370 submissions in what has become the “Olympics of ADMET prediction."

    Apr 2, 2026

  • From Data to Discovery: Inside the Bio-IT Hackathon

    Bio-IT World | At a time when research is generating more data than ever before, a growing question looms: how do scientists actually make use of it? At the Bio-IT World Hackathon, organizers believe that the answer lies not just in better tools, but in better collaboration—and increasingly, in the intelligent use of AI. Allissa Dillman, founder and CEO of BioData Sage, and LaFrancis Gibson, manager for health promotion at ORAU, h join the newest episode of Trends from the Trenches with host Allison Proffitt to discuss how the Hackathon brings together a diverse mix of participants to work intensively on real-world biomedical data challenges.

    Apr 1, 2026

  • Mapping the Trillion-Gene Universe: The Startup That Wants to Teach AI the Language of Life

    Bio-IT World | Basecamp Research, the AI-biology lab, has announced the Trillion Gene Atlas: a plan to collect genomic data from more than 100 million species across 31 countries, expand the known genetic universe by a factor of 100, and compress what it estimates would be 20 years of data processing into under two years.

    Mar 30, 2026

  • The Value of Prediction, and Cost of Success, in Drug Hunting

    Bio-IT World | Across the pharmaceutical industry, generative artificial intelligence is now running an estimated 10 to 20 million predictions a day in a quest to accelerate drug discovery by exploring new molecules and chemical reactions at an unprecedented pace. Access to hardware determines AI capabilities, but the tech-driven process of making medicines is still “done by people for people,” with a human in the loop calling the shots and running the machinery.

    Mar 26, 2026

  • Follow the Money: Brain-Computer Retinal Implant, Expansion of Alzheimer’s Platform, Migraine Therapies

    Bio-IT World | Science Corporation accelerates the commercialization of their brain-computer interface retinal implant, PRIMA; Cognito Therapeutics prepares for commercial launch of their Spectris platform; Slate Medicines receives in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody targeting PACAP for the prevention of migraine and other headache disorders; and more.

    Mar 25, 2026